Beijing Health (Holdings) Limited (2389.HK)
HKD 0.08
(0.0%)
HKD 0.08
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.92 Million | -11.19 Million | 1.98 Million | 26.72 Million | -103.19 Million | -352.06 Million |
| Net Income | -61.88 Million | -97.69 Million | -39.41 Million | -185.32 Million | -422.39 Million | 43.45 Million |
| Depreciation & Amortization | 24.21 Million | 26 Million | 34.18 Million | 32.62 Million | 33.42 Million | 11.9 Million |
| Deferred income taxes | - | - | - | - | -88.03 Million | 4.26 Million |
| Stock-based compensation | - | - | - | - | 297 Thousand | 5.68 Million |
| Change in working capital | -22.67 Million | 4.92 Million | 15.84 Million | 72.78 Million | -30.17 Million | -9.95 Million |
| Other non-cash items | 79.75 Million | 55.57 Million | -8.63 Million | 106.64 Million | 403.69 Million | -407.42 Million |
| Investing Cash Flow | 16.24 Million | -4.73 Million | -227.83 Million | 122.22 Million | -160.86 Million | 607.05 Million |
| Investments in PPE | -1.37 Million | -1.14 Million | -1.57 Million | -9.7 Million | -31.08 Million | -38.04 Million |
| Acquisitions | -34.07 Million | -20.99 Million | 21 Thousand | 228.42 Million | -7.72 Million | 330.85 Million |
| Investment purchases | -367.26 Million | -709.33 Million | -229.52 Million | -128.04 Million | -27.86 Million | -186.21 Million |
| Sales/Maturities of investments | 418.95 Million | 716.79 Million | 3.25 Million | 11.33 Million | 8.01 Million | 3.78 Million |
| Other Investing Activities | 76.13 Million | 9.95 Million | -202.74 Million | 20.21 Million | -102.19 Million | 496.66 Million |
| Financing Cash Flow | -32.68 Million | -16.27 Million | -20.46 Million | -83.56 Million | -77.26 Million | 75.5 Million |
| Debt repayment | -25.55 Million | -8.15 Million | -6.02 Million | -77.49 Million | -64.29 Million | -39.58 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.92 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -903 Thousand | -6.19 Million | -14.43 Million | -6.06 Million | -12.97 Million | 115.09 Million |
| Accounts receivables | 831 Thousand | 12.4 Million | 1.08 Million | 7.06 Million | -22.61 Million | -9.46 Million |
| Accounts payables | 7.3 Million | -24.67 Million | 12.1 Million | -1.04 Million | 17.24 Million | 3.27 Million |
| Inventory | -40 Thousand | 25.36 Million | -18.92 Million | -45.41 Million | -15.52 Million | -488 Thousand |
| Other working capital | -30.77 Million | -8.17 Million | 21.58 Million | 112.17 Million | -9.28 Million | -3.27 Million |
| Cash at beginning of period | 168.74 Million | 243.13 Million | 479.63 Million | 442.37 Million | 775.87 Million | 471.17 Million |
| Cash at end of period | 111.36 Million | 168.74 Million | 243.13 Million | 479.63 Million | 442.37 Million | 764.11 Million |
| Capital Expenditure | -1.37 Million | -1.14 Million | -1.57 Million | -9.7 Million | -31.08 Million | -38.04 Million |
| Effect of forex changes on cash | -3.03 Million | -17.2 Million | 9.8 Million | -28.12 Million | 10.46 Million | -37.55 Million |
| Net cash flow / Change in cash | -57.38 Million | -74.38 Million | -236.5 Million | 37.26 Million | -333.5 Million | 292.94 Million |
| Free Cash Flow | -22.29 Million | -12.33 Million | 406 Thousand | 17.01 Million | -134.28 Million | -390.11 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.41 Million | -45.86 Million | -61.88 Million | -16.01 Million | -97.69 Million | -64.87 Million |
| Depreciation & Amortization | 10.97 Million | 12.03 Million | 24.21 Million | 12.17 Million | 26 Million | 11.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.39 Million | -13.13 Million | -22.67 Million | -9.58 Million | 4.92 Million | -13.81 Million |
| Other non-cash items | 13.9 Million | 15.54 Million | 79.75 Million | 22.63 Million | 55.57 Million | 63.97 Million |
| Investing Cash Flow | -11.99 Million | 81.7 Million | 16.24 Million | -18.82 Million | -4.73 Million | 94.01 Million |
| Investments in PPE | -2.57 Million | -1.02 Million | -1.37 Million | -343 Thousand | -1.14 Million | -242 Thousand |
| Acquisitions | -52.96 Million | -34.07 Million | -34.07 Million | 6.6 Million | -20.99 Million | -1.74 Million |
| Investment purchases | -137.84 Million | -81.19 Million | -367.26 Million | -286.06 Million | -709.33 Million | -422.87 Million |
| Sales/Maturities of investments | 176.67 Million | 151.36 Million | 418.95 Million | 267.58 Million | 716.79 Million | 508.92 Million |
| Other Investing Activities | 43.55 Million | 82.73 Million | 76.13 Million | -6.6 Million | 9.95 Million | 9.95 Million |
| Financing Cash Flow | -2.77 Million | -37.03 Million | -32.68 Million | -31.1 Million | -16.27 Million | -12.46 Million |
| Debt repayment | -1.92 Million | -409 Thousand | -25.55 Million | -25.96 Million | -8.15 Million | -9.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.92 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -851 Thousand | -37.03 Million | -903 Thousand | -917 Thousand | -6.19 Million | 196 Thousand |
| Accounts receivables | -182 Thousand | 11.26 Million | 831 Thousand | -10.43 Million | 12.4 Million | 24.15 Million |
| Accounts payables | -5.57 Million | 46 Thousand | 7.3 Million | 7.25 Million | -24.67 Million | -18.03 Million |
| Inventory | 9.51 Million | -17.67 Million | -40 Thousand | 17.63 Million | 25.36 Million | 2.22 Million |
| Other working capital | -14.73 Million | -6.72 Million | -30.77 Million | -24.04 Million | -8.17 Million | -22.16 Million |
| Cash at beginning of period | 111.36 Million | 140.07 Million | 168.74 Million | 168.74 Million | 243.13 Million | 142.04 Million |
| Cash at end of period | 100.99 Million | 111.36 Million | 111.36 Million | 140.07 Million | 168.74 Million | 168.74 Million |
| Capital Expenditure | -2.57 Million | -1.02 Million | -1.37 Million | -343 Thousand | -1.14 Million | -242 Thousand |
| Effect of forex changes on cash | -615 Thousand | - | -3.03 Million | -3.03 Million | -17.2 Million | -11.64 Million |
| Net cash flow / Change in cash | -10.36 Million | -28.71 Million | -57.38 Million | -28.67 Million | -74.38 Million | 26.7 Million |
| Free Cash Flow | -39.51 Million | -32.44 Million | -22.29 Million | -1.02 Million | -12.33 Million | -18.46 Million |
300978
0URY
ESBS
CRRVF
6916
CASI